Clinical Risk Factors of Thromboembolic and Major Bleeding Events for Patients with Atrial Fibrillation Treated with Rivaroxaban in Japan-Reference-Cited by-同舟云学术

Clinical Risk Factors of Thromboembolic and Major Bleeding Events for Patients with Atrial Fibrillation Treated with Rivaroxaban in Japan

Published:2020-04 Issue:4 Volume:29 Page:104584
ISSN:1052-3057
Container-title:Journal of Stroke and Cerebrovascular Diseases
language:en
Short-container-title:Journal of Stroke and Cerebrovascular Diseases

Author:

Miyamoto Susumu,Ikeda Takanori,Ogawa Satoshi,Kitazono Takanari,Nakagawara Jyoji,Minematsu Kazuo,Murakawa Yuji^ORCID,Iwashiro Sanghun,Takeichi Makiko,Kidani Yoko^ORCID,Okayama Yutaka,Sunaya Toshiyuki,Sato Shoichiro^ORCID,Yamanaka Satoshi

Funder

Bayer Yakuhin, Ltd

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Clinical Neurology,Rehabilitation,Surgery

Reference35 articles.

1. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study;Chugh;Circulation,2014

2. Global epidemiology of atrial fibrillation;Rahman;Nat Rev Cardiol,2014

3. Prevalence of atrial fibrillation in the general population of Japan: an analysis based on periodic health examination;Inoue;Int J Cardiol,2009

4. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates;Kannel;Am J Cardiol,1998

5. A population-based study of mortality among patients with atrial fibrillation or flutter;Vidaillet;Am J Med,2002

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nomogram for predicting bleeding events in nonvalvular atrial fibrillation patients receiving rivaroxaban: A retrospective study;Health Science Reports;2024-01

2. Increased major bleeding incidence in atrial fibrillation patients with apixaban: a review of Japanese post-marketing surveillance studies of direct oral anticoagulants;European Journal of Clinical Pharmacology;2023-03-14

3. Safety of recanalization therapy in acute ischemic stroke patients on direct oral anticoagulant therapy: An updated systematic review and meta-analysis;Annals of Indian Academy of Neurology;2022

4. Rivaroxaban in patients with atrial fibrillation: from research to real practice (based on REGistry of Long-term AnTithrombotic TherApy-2 (REGATA));Aterotromboz = Atherothrombosis;2021-07-13

5. Experience of using idarucizumab, specific antagonist of dabigatran, in Russia;Medical alphabet;2020-11-02